Main Article Content
Abstract
Background. Clinical autopsy is the only procedure that verifies antemortem diagnosis against pathological truth, yet in Indonesian tertiary hospitals refusal is the norm and its determinants and medicolegal consequences remain unquantified.
Objective. To determine the rate of clinical autopsy refusal, quantify its sociocultural determinants while separating ethnic from religious influence, and estimate its consequences for diagnostic discrepancy and time to correct diagnosis.
Methods. This STROBE-reported retrospective cohort study analysed 324 consecutive adult in-hospital deaths across three tertiary referral hospitals in Palembang, 2019–2023. The primary outcome was next-of-kin refusal of autopsy consent; secondary outcomes were Goldman-class discrepancy and time to correct diagnosis (censored at day 90). Proportions carry Wilson intervals; tests were checked against Monte-Carlo exact methods, trend tests and Benjamini-Hochberg control.
Results. Refusal was 84.0% (272/324; 95% CI 79.6-87.5) and did not differ across hospitals (p = 0.330). Javanese ethnicity carried the strongest association (94.3% versus 77.7%; OR 4.71, 95% CI 2.05-10.82), with gradients across education (trend z = -3.87, p < 0.001) and income (z = -2.84, p = 0.005). Religious affiliation showed no association (p = 0.290). Any diagnostic discrepancy was commoner after refusal (61.4% versus 36.5%; OR 2.76, 95% CI 1.49-5.11), whereas the major-discrepancy contrast did not reach significance (26.1% versus 13.5%; OR 2.27, 95% CI 0.98-5.27). Median time to correct diagnosis was 19 versus 5 days (p < 0.001).
Conclusion. Autopsy refusal in Indonesia tracks ethnic mortuary practice and socioeconomic position rather than religious affiliation, redirecting policy towards ritual accommodation and mandatory mortality audit where consent is declined.
Keywords
Article Details
Authors retain copyright and publishing rights in articles published in Sriwijaya Journal of Forensic and Medicolegal (SJFM), without transfer of copyright to the journal or publisher.
The authors remain the holders of commercial rights in their work. Third-party reuse is subject to the applicable article license. The journal’s standard license is CC BY-NC-SA 4.0.
Copyright in the journal website’s presentation is separate from copyright in individual articles. Website branding and footer notices do not change the authors’ rights.
